Importantly, higher VEGF levels in cerebrospinal fluid (CSF) have been associated with increased brain metabolism, less hippocampal atrophy and cognitive decline over time in the presence of elevated AD biomarkers (Hohman et al., 2015; Tubi et al., 2021). The gene discussed is VEGFA; the disease is Alzheimer disease.